Wet macular degeneration is a chronic eye disorder that induces vague vision or a blind spot in the patient's visual field.
This report contains market size and forecasts of Wet Macular Degeneration in Global, including the following market information:
Global Wet Macular Degeneration Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Wet Macular Degeneration market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Wet Macular Degeneration include Pfizer Inc., F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Novartis AG, Bausch Health Companies Inc., Apellis Pharmaceuticals Inc., GlaxoSmithKline plc, Ophthotech Corporation and Gilead Sciences, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Wet Macular Degeneration companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Wet Macular Degeneration Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Wet Macular Degeneration Market Segment Percentages, by Type, 2021 (%)
by Drug
Lucentis
Eylea
Avastin
Others
by Route of Administration
Intravitreal
Intravenous
Global Wet Macular Degeneration Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Wet Macular Degeneration Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Research Institutes
Academic Institutes
Global Wet Macular Degeneration Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Wet Macular Degeneration Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Wet Macular Degeneration revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Wet Macular Degeneration revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
F. Hoffmann-La Roche AG
Regeneron Pharmaceuticals, Inc.
Novartis AG
Bausch Health Companies Inc.
Apellis Pharmaceuticals Inc.
GlaxoSmithKline plc
Ophthotech Corporation
Gilead Sciences, Inc.
Alcon
Genzyme Corporation
Boehringer Ingelheim GmbH
EyeGate Pharmaceuticals, Inc.
EyeCyte, Inc.
PanOptica Inc